Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized docetaxel dosing in breast cancer
ChiCTR1900024133Phase 4Recruiting
- Sponsor
- Shi Qingping
- Start
- Jun 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of docetaxel in breast cancer, sponsored by Shi Qingping. Primary endpoint: Blood concentration. Started Jun 2019; status: recruiting.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR1900024133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024133.